Home > Financial Ratios > HIKAL

HIKAL
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HIKAL
Please provide your vote to see the results

HIKAL Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.712.67-24.025.3618.42

What is the latest Core EBITDA Growth ratio of HIKAL ?

The latest Core EBITDA Growth ratio of HIKAL is 23.71 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.71
Mar20242.67
Mar2023-24.02
Mar20225.36
Mar202118.42

How is Core EBITDA Growth of HIKAL Trending?

Years Core EBITDA Growth % Change
Mar2025 23.71
788.01
Mar2024 2.67
Positive
Mar2023 -24.02
Negative
Mar2022 5.36
-70.90
Mar2021 18.42 -

Other Financial Ratios of HIKAL


Compare Core EBITDA Growth ratio of peers of HIKAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HIKAL ₹2,963.5 Cr -1.1% -5.2% -31.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,751.0 Cr 1.6% 8.2% -8.8% Stock Analytics
DIVIS LABORATORIES ₹176,634.0 Cr -0.8% 14.4% 12.2% Stock Analytics
CIPLA ₹124,437.0 Cr -3.9% 5.5% 5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,871.0 Cr -0.5% 1% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,333.0 Cr -2.1% -0% -2% Stock Analytics


HIKAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HIKAL

-1.1%

-5.2%

-31.3%

SENSEX

-0.2%

5%

5.4%


You may also like the below Video Courses